Hepatitis C Virus NS5A Drug Resistance HEPCNS5A

Synonyms

Allscripts (AEHR) Order Name

Hepatitis C Virus NS5A Drug Resistance

Sunrise Clinical Manager (SCM) Order Name

Hepatitis C Virus NS5A Drug Resistance

Clinical Info

Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5A inhibitors. Assay should be used for patients with documented HCV genotype 1.

Specimen Type

Container

Lavender Top Tube

Collection Instructions

Container/Tube: PPT™ tubes or Lavender (EDTA) tube
Specimen: 2 mL Plasma ( 1 mL min)
Transport Temperature: Frozen plasma
 
Note: Centrifuge specimen within six hours of collection, remove plasma, transfer specimen to polypropylene screw-capped tubes, and freeze. Specimens drawn into PPT™ tubes need to be centrifuged within six hours and frozen.
 
Limitations This procedure may not be successful when the HCV viral load is <500 IU/mL. This assay requires an HCV genotype of either 1a or 1b
 

Transport Instructions

Frozen plasma

Specimen Stability

Methodology

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing

Days Performed

TEST DELAY Current TAT 19-23 Days
TAT: 11-15 Days

Performing Laboratory

LabCorp-Monogram Bioscience

CPT

87900
87902

PDM

1659077

Result Interpretation

See Report

Forms